Company news

Opthea Limited news in 2024

Opthea Limited's news releases, calls and decks from 2024, newest first.

View company

Opthea's Wet AMD Program to be Featured at FLORetina 2024

November 25, 2024

Opthea Received A$15.9 Million R&D Tax Incentive

November 14, 2024

Chair's Address to Shareholders

November 14, 2024

Opthea Corporate Presentation - Oct 2024

October 27, 2024

Opthea EURetina Symposium 2024

September 26, 2024

Opthea Joins the S&P/ASX 300 Index

September 22, 2024

Opthea Announces Completion of Drug Substance Campaign

September 18, 2024

Opthea Corporate Presentation - September 2024

September 8, 2024

S&P DJI Announces September 2024 Quarterly Rebalance

September 6, 2024

Opthea Reports Full-Year Results

August 30, 2024

Opthea Preliminary Final and Annual Report

August 30, 2024

Updated Quarterly Report and Cashflow

August 1, 2024

Opthea Welcomes Retina Leaders to its Medical Advisory Board

July 17, 2024

Security Class Reinstatement to Quotation- OPTOB

July 17, 2024

Opthea Announces Results of Retail Entitlement of A$55.9m

July 14, 2024

Security Class Suspension from Quotation OPTOB

July 10, 2024

Opthea Announces Publication on VEGF- C and D

July 9, 2024

Opthea A$55.0m (US$36.9m) Retail Entitlement Offer Opens

June 18, 2024

Opthea Completes Placement & Institutional Entitlement Offer

June 13, 2024

Opthea - Prospectus 2024

June 12, 2024

Opthea Equity Raise Investor Presentation

June 12, 2024

Opthea Annouces Equity Raise

June 12, 2024

Trading Halt - Accelerated Offer

June 11, 2024

Opthea to Present at Clinical Trials at the Summit Meeting

June 2, 2024

Opthea Completes Enrollment in Phase 3 Clinical Program

May 27, 2024

Opthea Corporate Presentation - April 2024

April 4, 2024

Opthea Key Opinion Leader Even on Sozinibercept

April 3, 2024

Opthea Corporate Presentation - March 2024

March 4, 2024

Half Yearly Report and Accounts

February 28, 2024

Opthea Reports Half-Year Results and Business Update

February 28, 2024

Opthea Completes Enrollment in First Trial of Sozinibercept

February 14, 2024

Decks in 2024